Stanton P K, Heinemann U, Muller W
Departments of Neuroscience and Neurology, Albert Einstein College of Medicine, Bronx, New York 10461-1602, USA.
J Neurosci. 2001 Oct 1;21(19):RC167. doi: 10.1523/JNEUROSCI.21-19-j0002.2001.
A persistent question concerning mechanisms underlying long-term, activity-dependent synaptic plasticity is whether the sites of alterations are presynaptic, postsynaptic, or both. Recently, we discovered a chemical method of inducing long-term depression (LTD) of synaptic strength at Schaffer collateral-CA1 synapses by simultaneously elevating [cGMP] and inhibiting cAMP-dependent protein kinase (PKA). Chemical LTD (CLTD) is activity-independent, occluded by stimulus-evoked LTD, and requires access of pharmacologic agents to presynaptic terminals. In the present study, we used fluorescence and two-photon imaging of presynaptic terminals with the fluorescent dye N-(3-triethylammoniumpropyl)-4-(4-(dibutylamino)styryl) pyridinium dibromide (FM1-43) to determine directly if inducing CLTD is associated with a long-term reduction in transmitter release. In presynaptic Schaffer collateral-CA1 terminals of control hippocampal slices loaded with FM1-43, electrical stimulation (10 Hz/2 min) elicited a frequency-dependent destaining that peaked at 20% reduction in fluorescence. In contrast, when we first induced CLTD by a 30 min treatment of slices with the type V phosphodiesterase inhibitor zaprinast (20 microm) plus the PKA inhibitor N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89; 10 microm), then washed for 60 min, the destaining of FM1-43 fluorescence evoked by the same stimulation was reduced to 4%. Treatment and washout of slices with either drug singly had a significantly smaller effect on stimulus-evoked FM1-43 destaining. Only CLTD was associated with virtually complete suppression of stimulus-evoked FM1-43 release, the first direct evidence for at least one form of LTD being mediated by persistent reduction of presynaptic transmitter release.
一个关于长期的、活动依赖型突触可塑性潜在机制的持久问题是,改变的位点是在突触前、突触后,还是两者皆有。最近,我们发现了一种化学方法,通过同时提高[cGMP]并抑制环磷酸腺苷依赖性蛋白激酶(PKA),来诱导海马体中沙费尔侧支- CA1突触处突触强度的长期抑制(LTD)。化学性LTD(CLTD)不依赖于活动,会被刺激诱发的LTD所阻断,并且需要药理试剂进入突触前终末。在本研究中,我们使用荧光染料N-(3-三乙铵丙基)-4-(4-(二丁基氨基)苯乙烯基)吡啶二溴化物(FM1-43)对突触前终末进行荧光和双光子成像,以直接确定诱导CLTD是否与神经递质释放的长期减少有关。在装载了FM-43的对照海马体切片的突触前沙费尔侧支- CA1终末中,电刺激(10赫兹/2分钟)引发了频率依赖性的去染色,荧光减少20%时达到峰值。相比之下,当我们先用V型磷酸二酯酶抑制剂扎普司特(20微摩尔)加PKA抑制剂N-[2-(对溴肉桂氨基)乙基]-5-异喹啉磺酰胺(H-89;10微摩尔)对切片进行30分钟处理以诱导CLTD,然后冲洗60分钟时,相同刺激引发的FM1-43荧光去染色减少到了4%。单独用这两种药物中的任何一种处理并冲洗切片,对刺激诱发的FM1-43去染色的影响都要小得多。只有CLTD与刺激诱发的FM1-43释放几乎完全被抑制有关,这是至少一种形式的LTD由突触前神经递质释放持续减少介导的首个直接证据。